Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-24

Clinical Trial Update: Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rivaroxaban to warfarin for post-operative atrial fibrillation after cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)
  • Warfarin (warfarin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Atrial Fibrillation, Stroke | Phase 3 | Status: COMPLETED